SCHEMBL5950232

SCHEMBL5950232

CC(=O)Nc1ccc(N2CCC[C@H](NC(=O)C34CC5CC(C3)C(=O)C(C5)C4)C2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
GAA P10253 4/20 0.46
MAPT P10636 3/20 0.46
KDM4E B2RXH2 2/20 0.46
GFER P55789 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
CNR1 P21554 1/20 0.44
FPR1 P21462 2/20 0.43
FPR2 P25090 2/20 0.43
POLB P06746 1/20 0.42
EPHX1 P07099 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
NPC1 O15118 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 1/20 0.37
DDB1 Q16531 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4006388 1.00 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL5950713 0.87 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL4011966 0.87 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL4010313 0.78 CNR1 (0.47) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL28769935 0.78 CNR1 (0.43) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL4142873 0.77 CNR1 (0.54) ALDH1A1MEN1KMT2AMAPTCNR1
SCHEMBL4002885 0.77 CNR1 (0.43) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL4153054 0.77 CNR1 (0.43) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL4002412 0.74 EPHX1 (0.45) KMT2AGAAEPHX1L3MBTL1LMNA
SCHEMBL5950384 0.74 SYK (0.40) ALDH1A1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122197-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2006-06-08 US claimed
US-20060122197-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2006-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122197-A1 Amido compounds and their use as pharmaceuticals HSD11B1, CYP11B1, HSD11B2 ALDH1A1 311/4885MEN1 379/4885KMT2A 3418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.